GENESYS INTER CORPORATION Fair Value
GENESYS-RE · Current price ₹122
| Method | Fair value | Status |
|---|---|---|
| Residual income | — | Needs a book value per share |
| Relative P/E | — | Needs positive EPS |
| Graham floor | — | Needs positive EPS |
| Analyst target | ₹641 | Street consensus 12-month target price |
Is GENESYS INTER CORPORATION undervalued?
DocStoX estimates the fair value of GENESYS INTER CORPORATION at ₹641 per share, versus the current market price of ₹122. That puts the stock about +425.4% below our fair-value estimate, which we read as "Buy". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 1 independent method: Analyst target (₹641). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹545 (bear) to ₹641 (base) to ₹737 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
More on GENESYS INTER CORPORATION
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.